Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.

Head & Neck
Yushi UekiArata Horii

Abstract

It was reported that treatment outcomes of the salvage chemotherapy (SCT) following nivolumab are fairly good compared with those of nivolumab itself. However, predictive factors of SCT for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) were not determined. Twenty-one R/M HNSCC patients received SCT following nivolumab. The treatment outcome and predictive factors for the favorable response to SCT were investigated. The objective response rate (ORR) and the disease control rate of SCT were 52.4% and 81.0%, respectively. The median progression-free survival and the median overall survival time were 5.4 and 12.9 months, respectively. Patients with positive programmed death-ligand 1 (PD-L1) expression showed greater tumor shrinkage evaluated by the response evaluation criteria in solid tumors and higher ORR than those with negative PD-L1 expression. Treatment outcome of SCT following nivolumab in R/M HNSCC was favorable. PD-L1 expression may be a predictive factor of SCT.

References

Jan 25, 2007·International Journal of Colorectal Disease·Donald C McMillanColin S McArdle
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jun 19, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Galina V ShurinMichael R Shurin
Aug 26, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R HittUNKNOWN Spanish Head and Neck Cancer Cooperative Group (TTCC)
Nov 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jens H W PahlArjan C Lankester
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Sep 26, 2015·The New England Journal of Medicine·Robert J MotzerUNKNOWN CheckMate 025 Investigators
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Dec 2, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Gustavo SchvartsmanWilliam N William
Oct 2, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Khalil SalehCaroline Even

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.